A citation-based method for searching scientific literature

Timothy J Ley, Li Ding, Matthew J Walter, Michael D McLellan, Tamara Lamprecht, David E Larson, Cyriac Kandoth, Jacqueline E Payton, Jack Baty, John Welch, Christopher C Harris, Cheryl F Lichti, R Reid Townsend, Robert S Fulton, David J Dooling, Daniel C Koboldt, Heather Schmidt, Qunyuan Zhang, John R Osborne, Ling Lin, Michelle O'Laughlin, Joshua F McMichael, Kim D Delehaunty, Sean D McGrath, Lucinda A Fulton, Vincent J Magrini, Tammi L Vickery, Jasreet Hundal, Lisa L Cook, Joshua J Conyers, Gary W Swift, Jerry P Reed, Patricia A Alldredge, Todd Wylie, Jason Walker, Joelle Kalicki, Mark A Watson, Sharon Heath, William D Shannon, Nobish Varghese, Rakesh Nagarajan, Peter Westervelt, Michael H Tomasson, Daniel C Link, Timothy A Graubert, John F DiPersio, Elaine R Mardis, Richard K Wilson. N Engl J Med 2010
Times Cited: 1262







List of co-cited articles
1013 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
Timothy J Ley, Christopher Miller, Li Ding, Benjamin J Raphael, Andrew J Mungall, A Gordon Robertson, Katherine Hoadley, Timothy J Triche, Peter W Laird, Jack D Baty,[...]. N Engl J Med 2013
43

Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Nicola D Roberts, Nicola E Potter, Michael Heuser, Felicitas Thol, Niccolo Bolli,[...]. N Engl J Med 2016
36

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
30

The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.
David A Russler-Germain, David H Spencer, Margaret A Young, Tamara L Lamprecht, Christopher A Miller, Robert Fulton, Matthew R Meyer, Petra Erdmann-Gilmore, R Reid Townsend, Richard K Wilson,[...]. Cancer Cell 2014
241
23

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
23

Mutation in TET2 in myeloid cancers.
François Delhommeau, Sabrina Dupont, Véronique Della Valle, Chloé James, Severine Trannoy, Aline Massé, Olivier Kosmider, Jean-Pierre Le Couedic, Fabienne Robert, Antonio Alberdi,[...]. N Engl J Med 2009
22

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia.
Xiao-Jing Yan, Jie Xu, Zhao-Hui Gu, Chun-Ming Pan, Gang Lu, Yang Shen, Jing-Yi Shi, Yong-Mei Zhu, Lin Tang, Xiao-Wei Zhang,[...]. Nat Genet 2011
542
20

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
Maria E Figueroa, Omar Abdel-Wahab, Chao Lu, Patrick S Ward, Jay Patel, Alan Shih, Yushan Li, Neha Bhagwat, Aparna Vasanthakumar, Hugo F Fernandez,[...]. Cancer Cell 2010
20

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
Jay P Patel, Mithat Gönen, Maria E Figueroa, Hugo Fernandez, Zhuoxin Sun, Janis Racevskis, Pieter Van Vlierberghe, Igor Dolgalev, Sabrena Thomas, Olga Aminova,[...]. N Engl J Med 2012
20

The origin and evolution of mutations in acute myeloid leukemia.
John S Welch, Timothy J Ley, Daniel C Link, Christopher A Miller, David E Larson, Daniel C Koboldt, Lukas D Wartman, Tamara L Lamprecht, Fulu Liu, Jun Xia,[...]. Cell 2012
989
18

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Giulio Genovese, Anna K Kähler, Robert E Handsaker, Johan Lindberg, Samuel A Rose, Samuel F Bakhoum, Kimberly Chambert, Eran Mick, Benjamin M Neale, Menachem Fromer,[...]. N Engl J Med 2014
18

Dnmt3a is essential for hematopoietic stem cell differentiation.
Grant A Challen, Deqiang Sun, Mira Jeong, Min Luo, Jaroslav Jelinek, Jonathan S Berg, Christoph Bock, Aparna Vasanthakumar, Hongcang Gu, Yuanxin Xi,[...]. Nat Genet 2011
635
18

DNMT3A in haematological malignancies.
Liubin Yang, Rachel Rau, Margaret A Goodell. Nat Rev Cancer 2015
241
17


The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
17

DNMT3A in Leukemia.
Lorenzo Brunetti, Michael C Gundry, Margaret A Goodell. Cold Spring Harb Perspect Med 2017
55
27

CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
David H Spencer, David A Russler-Germain, Shamika Ketkar, Nichole M Helton, Tamara L Lamprecht, Robert S Fulton, Catrina C Fronick, Michelle O'Laughlin, Sharon E Heath, Marwan Shinawi,[...]. Cell 2017
102
15

Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Mingchao Xie, Charles Lu, Jiayin Wang, Michael D McLellan, Kimberly J Johnson, Michael C Wendl, Joshua F McMichael, Heather K Schmidt, Venkata Yellapantula, Christopher A Miller,[...]. Nat Med 2014
913
14

Recurring mutations found by sequencing an acute myeloid leukemia genome.
Elaine R Mardis, Li Ding, David J Dooling, David E Larson, Michael D McLellan, Ken Chen, Daniel C Koboldt, Robert S Fulton, Kim D Delehaunty, Sean D McGrath,[...]. N Engl J Med 2009
14

Acute Myeloid Leukemia.
Hartmut Döhner, Daniel J Weisdorf, Clara D Bloomfield. N Engl J Med 2015
13

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Liran I Shlush, Sasan Zandi, Amanda Mitchell, Weihsu Claire Chen, Joseph M Brandwein, Vikas Gupta, James A Kennedy, Aaron D Schimmer, Andre C Schuh, Karen W Yee,[...]. Nature 2014
878
13

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.
Olga A Guryanova, Kaitlyn Shank, Barbara Spitzer, Luisa Luciani, Richard P Koche, Francine E Garrett-Bakelman, Chezi Ganzel, Benjamin H Durham, Abhinita Mohanty, Gregor Hoermann,[...]. Nat Med 2016
111
12

Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
Allison Mayle, Liubin Yang, Benjamin Rodriguez, Ting Zhou, Edmund Chang, Choladda V Curry, Grant A Challen, Wei Li, David Wheeler, Vivienne I Rebel,[...]. Blood 2015
142
12

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
Hartmut Döhner, Elihu H Estey, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Alan K Burnett, Hervé Dombret, Pierre Fenaux, David Grimwade, Richard A Larson,[...]. Blood 2010
11

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem, Peter Van Loo, Chris J Yoon, Peter Ellis, David C Wedge, Andrea Pellagatti,[...]. Blood 2013
11

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, S Schnittger, M Sanada, A Kon, T Alpermann,[...]. Leukemia 2014
825
11

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
David Grimwade, Robert K Hills, Anthony V Moorman, Helen Walker, Stephen Chatters, Anthony H Goldstone, Keith Wheatley, Christine J Harrison, Alan K Burnett. Blood 2010
11

Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
Felicitas Thol, Frederik Damm, Andrea Lüdeking, Claudia Winschel, Katharina Wagner, Michael Morgan, Haiyang Yun, Gudrun Göhring, Brigitte Schlegelberger, Dieter Hoelzer,[...]. J Clin Oncol 2011
273
11

Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.
Ana Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia Erpelinck-Verschueren, Veronika Rockova, Mathijs Sanders, Saman Abbas, Maria E Figueroa, Annelieke Zeilemaker, Ari Melnick, Bob Löwenberg,[...]. Blood 2012
177
11

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.
M J Walter, L Ding, D Shen, J Shao, M Grillot, M McLellan, R Fulton, H Schmidt, J Kalicki-Veizer, M O'Laughlin,[...]. Leukemia 2011
380
11

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
Li Ding, Timothy J Ley, David E Larson, Christopher A Miller, Daniel C Koboldt, John S Welch, Julie K Ritchey, Margaret A Young, Tamara Lamprecht, Michael D McLellan,[...]. Nature 2012
10

Frequent pathway mutations of splicing machinery in myelodysplasia.
Kenichi Yoshida, Masashi Sanada, Yuichi Shiraishi, Daniel Nowak, Yasunobu Nagata, Ryo Yamamoto, Yusuke Sato, Aiko Sato-Otsubo, Ayana Kon, Masao Nagasaki,[...]. Nature 2011
10


Large conserved domains of low DNA methylation maintained by Dnmt3a.
Mira Jeong, Deqiang Sun, Min Luo, Yun Huang, Grant A Challen, Benjamin Rodriguez, Xiaotian Zhang, Lukas Chavez, Hui Wang, Rebecca Hannah,[...]. Nat Genet 2014
197
10

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).
Verena I Gaidzik, Richard F Schlenk, Peter Paschka, Anja Stölzle, Daniela Späth, Andrea Kuendgen, Marie von Lilienfeld-Toal, Wolfram Brugger, Hans Günter Derigs, Stephan Kremers,[...]. Blood 2013
113
9

Landscape of TET2 mutations in acute myeloid leukemia.
S Weissmann, T Alpermann, V Grossmann, A Kowarsch, N Nadarajah, C Eder, F Dicker, A Fasan, C Haferlach, T Haferlach,[...]. Leukemia 2012
136
9

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
Klaus H Metzeler, Tobias Herold, Maja Rothenberg-Thurley, Susanne Amler, Maria C Sauerland, Dennis Görlich, Stephanie Schneider, Nikola P Konstandin, Annika Dufour, Kathrin Bräundl,[...]. Blood 2016
251
9


Functional genomic landscape of acute myeloid leukaemia.
Jeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, Beth Wilmot, Stephen E Kurtz, Samantha L Savage, Nicola Long, Anna Reister Schultz, Elie Traer, Melissa Abel,[...]. Nature 2018
272
8

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.
Timothy J Ley, Elaine R Mardis, Li Ding, Bob Fulton, Michael D McLellan, Ken Chen, David Dooling, Brian H Dunford-Shore, Sean McGrath, Matthew Hickenbotham,[...]. Nature 2008
883
8

Prediction of acute myeloid leukaemia risk in healthy individuals.
Sagi Abelson, Grace Collord, Stanley W K Ng, Omer Weissbrod, Netta Mendelson Cohen, Elisabeth Niemeyer, Noam Barda, Philip C Zuzarte, Lawrence Heisler, Yogi Sundaravadanam,[...]. Nature 2018
261
8

Somatic mutations precede acute myeloid leukemia years before diagnosis.
Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, Michael S Simon, Gloria Cheang, Sangmin Lee, Michael Samuel, Ellen K Ritchie, Monica L Guzman, Karla V Ballman,[...]. Nat Med 2018
196
8

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Wen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, Chien-Yuan Chen, Hsin-An Hou, Yuan-Yeh Kuo, Ming-Cheng Lee, Bor-Sheng Ko, Jih-Luh Tang, Ming Yao,[...]. Blood 2011
194
8

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.
S Schnittger, C Eder, S Jeromin, T Alpermann, A Fasan, V Grossmann, A Kohlmann, T Illig, N Klopp, H-E Wichmann,[...]. Leukemia 2013
127
8

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Kelly Moran-Crusio, Linsey Reavie, Alan Shih, Omar Abdel-Wahab, Delphine Ndiaye-Lobry, Camille Lobry, Maria E Figueroa, Aparna Vasanthakumar, Jay Patel, Xinyang Zhao,[...]. Cancer Cell 2011
755
8

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.
Shinsuke Ito, Li Shen, Qing Dai, Susan C Wu, Leonard B Collins, James A Swenberg, Chuan He, Yi Zhang. Science 2011
8

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
Thomas Ernst, Andrew J Chase, Joannah Score, Claire E Hidalgo-Curtis, Catherine Bryant, Amy V Jones, Katherine Waghorn, Katerina Zoi, Fiona M Ross, Andreas Reiter,[...]. Nat Genet 2010
806
8

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.
Omar Abdel-Wahab, Ann Mullally, Cyrus Hedvat, Guillermo Garcia-Manero, Jay Patel, Martha Wadleigh, Sebastien Malinge, JinJuan Yao, Outi Kilpivaara, Rukhmi Bhat,[...]. Blood 2009
504
8

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
Courtney D DiNardo, Eytan M Stein, Stéphane de Botton, Gail J Roboz, Jessica K Altman, Alice S Mims, Ronan Swords, Robert H Collins, Gabriel N Mannis, Daniel A Pollyea,[...]. N Engl J Med 2018
524
8

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Alexander E Perl, Giovanni Martinelli, Jorge E Cortes, Andreas Neubauer, Ellin Berman, Stefania Paolini, Pau Montesinos, Maria R Baer, Richard A Larson, Celalettin Ustun,[...]. N Engl J Med 2019
263
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.